Diane Kadidlo was recently elected to the Board of Directors of the International Society for Cell & Gene Therapy (ISCT). As the Member Technologist for ISCT, Kadidlo will serve as one of two technologist representatives on the Board whose role it is to manage the governance and strategic oversight of the society.
“I’m very excited and honored to have been elected to ISCT’s Board and be part of promoting global initiatives and strategies through partnerships with academia, regulatory bodies and industry in the field of cell and gene therapy,” said Kadidlo.
Kadidlo is the facility director for Molecular and Cellular Therapeutics at the University of Minnesota, where she is responsible for the clinical manufacturing and product development of biotherapeutic agents produced. She oversees building operations including finance, supply management, environmental monitoring, critical systems and all equipment for the facility. In addition she directs the development of research protocols to clinical status with oversight of scale-up studies, budget development, project timelines, master batch production records, validation studies and clinical production.
She also serves as the technical supervisor of MHealth Fairview Cell Therapy Clinical Laboratory, which performs somatic cell and tissue graft engineering for hematopoietic transplantation and immune adoptive therapies in support of the U's Blood and Marrow Transplant program. She has more than 25 years experience in cell and tissue manufacturing, regulation and quality assurance.